Brown Advisory
ALDR

Brown Advisory’s Alder Biopharmaceuticals ALDR Stock Holding History

Brown Advisory’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-752,575
Closed -$7.71M – 1374
2018
Q4 		$7.71M Sell
752,575
-375,728
-33% -$4.81M 0.03% 361
2018
Q3 		$18.8M Buy
1,128,303
+49,707
+5% +$898K 0.05% 259
2018
Q2 		$17M Buy
1,078,596
+12,432
+1% +$189K 0.05% 260
2018
Q1 		$13.5M Buy
1,066,164
+203,579
+24% +$2.94M 0.04% 271
2017
Q4 		$9.88M Buy
862,585
+289,120
+50% +$3.23M 0.03% 316
2017
Q3 		$7.03M Buy
573,465
+35,630
+7% +$372K 0.02% 346
2017
Q2 		$6.16M Buy
537,835
+12,707
+2% +$235K 0.02% 377
2017
Q1 		$10.9M Buy
525,128
+27,175
+5% +$602K 0.04% 280
2016
Q4 		$10.4M Buy
497,953
+38,041
+8% +$989K 0.04% 283
2016
Q3 		$15.1M Buy
459,912
+33,422
+8% +$1.02M 0.05% 239
2016
Q2 		$10.7M Buy
426,490
+45,816
+12% +$1.24M 0.04% 273
2016
Q1 		$9.32M Buy
380,674
+1,095
+0.3% +$25.4K 0.03% 281
2015
Q4 		$12.5M Buy
379,579
+206,108
+119% +$6.97M 0.04% 250
2015
Q3 		$5.68M Buy
173,471
+101,135
+140% +$4.3M 0.02% 342
2015
Q2 		$3.83M Buy
+72,336
New +$2.63M 0.01% 373

Other funds holding ALDR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Brown Advisory's ALDR Position: Q1 2019 in Review

Brown Advisory sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 752,575 shares — an estimated $7.71M sold.

Brown Advisory first reported a position in ALDR in Q2 2015 and held it in 15 quarters. The position peaked at $18.8M in Q3 2018. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

  • Brown Advisory reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Brown Advisory sold 752,575 Alder Biopharmaceuticals shares in Q1 2019, an estimated $7.71M.
  • Brown Advisory first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 15 quarters.
  • Brown Advisory's Alder Biopharmaceuticals position peaked at $18.8M in Q3 2018.
  • 123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on Brown Advisory's 13F filing for Q1 2019, filed 15 May 2019.